07 Jan 2001

Collomack® (Collomack® Lösung) - Deutschland

Updated: 07 Jan 2001

Collomack®

Hyperkeratosen, Hühneraugen, Schwielen, Warzen.

Collomack® Description, Presentation and Dosage

Collomack® Description

Collomack® Drug Class Description

Kombinationen

Collomack® Drug Description

10 g enth.: Salicylsäure 2 g, Milchsäure 0,5 g, Polidocanol 0,2 g.

Collomack® Generic Name

Collomack® Lösung

Collomack® Presentation

Collomack® Presentation

Collomack®

Collomack® Manufacturer

Mack, Illert.

Related Learning Zones

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

Collomack® Dosage

Collomack® Adult Dosage

Dibutylphthalat, Ethylcellulose, Aceton.

Collomack® Precautions, Reactions and Contraindications

Collomack® Special Precautions

Collomack® Adverse Reactions

Collomack® Adverse Reactions

S 5

Related Drugs - Dermatology

Back to top